Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC for Halting Inflammation in Emphysema
NCT04918706Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2019
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived mesenchymal stromal cells in pulmonary emphysema, sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
pulmonary emphysema
Beyond the preview
Go deeper on NCT04918706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918706.